NM_004380.3:c.1331-32G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004380.3(CREBBP):​c.1331-32G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0248 in 1,613,734 control chromosomes in the GnomAD database, including 3,179 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 1585 hom., cov: 32)
Exomes 𝑓: 0.018 ( 1594 hom. )

Consequence

CREBBP
NM_004380.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.332

Publications

7 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-3782958-C-A is Benign according to our data. Variant chr16-3782958-C-A is described in ClinVar as Benign. ClinVar VariationId is 1238727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.268 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.1331-32G>T
intron
N/ANP_004371.2
CREBBP
NM_001079846.1
c.1217-32G>T
intron
N/ANP_001073315.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.1331-32G>T
intron
N/AENSP00000262367.5
CREBBP
ENST00000382070.7
TSL:1
c.1217-32G>T
intron
N/AENSP00000371502.3
CREBBP
ENST00000635753.1
TSL:5
n.64-32G>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0860
AC:
13061
AN:
151934
Hom.:
1574
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0434
Gnomad ASJ
AF:
0.0666
Gnomad EAS
AF:
0.0133
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00944
Gnomad OTH
AF:
0.0771
GnomAD2 exomes
AF:
0.0316
AC:
7935
AN:
250956
AF XY:
0.0265
show subpopulations
Gnomad AFR exome
AF:
0.282
Gnomad AMR exome
AF:
0.0201
Gnomad ASJ exome
AF:
0.0640
Gnomad EAS exome
AF:
0.0164
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.0102
Gnomad OTH exome
AF:
0.0233
GnomAD4 exome
AF:
0.0184
AC:
26883
AN:
1461682
Hom.:
1594
Cov.:
31
AF XY:
0.0175
AC XY:
12758
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.279
AC:
9337
AN:
33466
American (AMR)
AF:
0.0232
AC:
1037
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0631
AC:
1650
AN:
26134
East Asian (EAS)
AF:
0.0237
AC:
941
AN:
39700
South Asian (SAS)
AF:
0.0134
AC:
1153
AN:
86206
European-Finnish (FIN)
AF:
0.00187
AC:
100
AN:
53410
Middle Eastern (MID)
AF:
0.0536
AC:
309
AN:
5768
European-Non Finnish (NFE)
AF:
0.00929
AC:
10331
AN:
1111924
Other (OTH)
AF:
0.0335
AC:
2025
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1229
2458
3688
4917
6146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
560
1120
1680
2240
2800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0863
AC:
13119
AN:
152052
Hom.:
1585
Cov.:
32
AF XY:
0.0819
AC XY:
6086
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.272
AC:
11269
AN:
41422
American (AMR)
AF:
0.0434
AC:
662
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0666
AC:
231
AN:
3468
East Asian (EAS)
AF:
0.0131
AC:
68
AN:
5182
South Asian (SAS)
AF:
0.0137
AC:
66
AN:
4818
European-Finnish (FIN)
AF:
0.00123
AC:
13
AN:
10576
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00944
AC:
642
AN:
68000
Other (OTH)
AF:
0.0763
AC:
161
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
516
1031
1547
2062
2578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0271
Hom.:
56
Bravo
AF:
0.0996
Asia WGS
AF:
0.0380
AC:
134
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.8
DANN
Benign
0.55
PhyloP100
0.33
PromoterAI
-0.029
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs130025; hg19: chr16-3832959; API